Loading clinical trials...
Loading clinical trials...
A Multi-Center, Randomized, Double-Blind, Vehicle-Controlled, Sequential Group Comparison Study to Evaluate the Safety and Efficacy of Light Dose in Subjects With Port-wine Birthmarks Treated With Hemoporfin Photodynamic Therapy
Conditions
Interventions
Hemopfin+Green Light
Vehicle+Green Light
Locations
5
United States
UCI Health Beckman Laser Institute & Medical Clinic
Irvine, California, United States
Dermatology Cosmetic Associates of La Jolla, Inc. d/b/a West Dermatology Research Center
San Diego, California, United States
Miami Dermatology and Laser Institute
Miami, Florida, United States
Maryland Dermatology, Laser, Skin & Vein Institute
Hunt Valley, Maryland, United States
St. Luke's University Health Network
Bethlehem, Pennsylvania, United States
Start Date
September 21, 2024
Primary Completion Date
January 1, 2027
Completion Date
April 1, 2027
Last Updated
March 3, 2026
NCT04336163
NCT03181984
NCT05771311
NCT00540917
NCT01774552
NCT02051101
Lead Sponsor
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions